Klein Matthew B. bought CLPT
May 21, 2026 · Form 4 insider transaction
Klein Matthew B. bought 12,820 shares of ClearPoint Neuro, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,820
Price
$0.00
Total value
N/A
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMay 21, 2026
Filing dateMay 26, 2026
Shares owned after12,820
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.; The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.